Our use of cookies

We use necessary cookies to make our site work.

For more detailed information about the cookies we use, see our Cookie Policy.


Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Therapy Areas in the UK

Good health and wellbeing is a universal aspiration, and we continue to seek ways to help patients in achieving better health and a better quality of life. In the UK, we channel our energy into exploring solutions that we hope will make a difference to patients’ lives. We aim to help people with diseases that range from those affecting millions to those that affect relatively few. The health and wellbeing of patients is our primary focus, and we put the needs and views of patients, carers and healthcare professionals at the heart of the work we do. We aim to help patients in the following therapy areas: neuroscience, nephrology and endocrinology.

Neuroscience

Otsuka UK is committed to providing innovative solutions and aims to help people affected by mental health disorders. Otsuka UK has a long-term alliance with Lundbeck, a company that also has extensive experience in this area. 

Endocrinology

Otsuka UK is committed to providing solutions for hormone-related conditions.

Nephrology

Nephrology is a therapy area with a large unmet medical need. We work with patients and healthcare professionals to increase awareness of kidney diseases. We are also working with our partner Akebia, exploring chronic kidney disease. 

Date of preparation: November 2020 | Reference: UK-NPR-2000073

Date of preparation: November 2020 | Reference UK-NPR-2000084

Copyright © 2021 Otsuka Pharmaceuticals (U.K.) Ltd. All rights reserved.
Registered in England and Wales with company no. 03615891.
Registered office: Gallions, Wexham Springs, Framewood Road Wexham, Slough, Berkshire, SL3 6PJ

This website is for all those with an interest in Otsuka Pharmaceuticals (U.K.) Ltd.